Do we continue comfort medications for hospice patients with a prognosis of 20% or less chance of survival?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comfort Medications in Hospice Patients with PPS 20%

Yes, absolutely continue comfort medications for hospice patients at PPS 20%—in fact, symptom management should be intensified at this stage, not withdrawn. 1, 2

Understanding PPS 20% in Hospice Context

A Palliative Performance Scale (PPS) of 20% indicates a patient who is:

  • Totally bed-bound
  • Unable to perform any self-care
  • Experiencing extensive disease progression
  • Requiring total assistance with all activities
  • Typically within days to weeks of death 2

This functional status demands aggressive symptom palliation, not medication withdrawal. 1, 3

Core Principle: Comfort Measures Only Does Not Mean No Medications

The American College of Chest Physicians explicitly clarifies that "comfort measures only" occurs when treatments become more burdensome than the disease itself, but this specifically refers to life-prolonging interventions—not symptom management medications. 1 The goal shifts from cure to comfort, which actually requires maintaining and often intensifying medications that relieve suffering. 1

What to Continue and Intensify

Medications that should absolutely continue or be escalated include:

  • Opioids for pain and dyspnea (first-line treatment for breathlessness) 2, 4
  • Anxiolytics for anxiety and agitation 1, 5
  • Anticholinergics (glycopyrrolate, scopolamine) for secretions 2
  • Antiemetics for nausea 5
  • Medications for pruritus, delirium, and other distressing symptoms 5
  • Supplemental oxygen if it provides comfort 2, 5

The American Academy of Hospice and Palliative Medicine emphasizes that palliative treatments aimed at managing pain, dyspnea, anxiety, and other distressing symptoms should continue and are often enhanced as death approaches. 2, 3

The Doctrine of Double Effect

The American College of Chest Physicians endorses using the "doctrine of double effect" for end-stage patients, which morally justifies medications that relieve suffering (the intended good effect) even if they theoretically might hasten death (the unintended effect). 1 The intent is symptom relief, not death—this makes aggressive symptom management ethically and legally appropriate. 1

What Changes at PPS 20%

What you discontinue are treatments that:

  • Prolong life without improving comfort
  • Are burdensome (frequent blood draws, aggressive interventions)
  • No longer align with comfort-focused goals 1, 2

What you maintain or intensify are treatments that:

  • Relieve physical symptoms
  • Reduce psychological distress
  • Improve quality of remaining life 2, 3

Palliative Sedation for Refractory Symptoms

For patients at PPS 20% with intolerable symptoms despite optimal palliative care, continuous palliative sedation may be appropriate. 1 This is reserved for patients with terminal illness and life expectancy of weeks or less who suffer refractory physical or psychological symptoms after careful attention to all dimensions of suffering. 1 This represents intensification of comfort measures, not withdrawal.

Common Pitfall to Avoid

The most dangerous misconception is equating "hospice" or "comfort measures only" with medication withdrawal. 1, 2 The NCCN Guidelines and American College of Chest Physicians both emphasize that hospice patients are not required to withdraw all medical treatments—they focus on comfort-oriented care rather than curative treatments. 2 At PPS 20%, patients require more aggressive symptom management, not less. 3

The ACC/AHA guidelines for heart failure patients specifically state that greater attention and research need to be devoted to the provision of comfort measures in the final days of life, including relief of pain and dyspnea, with physicians becoming familiar with prescribing anxiolytics, sleeping medications, and narcotics to ease distress. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hospice Care Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hospice Recertification for Respiratory Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hospice Referral for ESRD Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.